{"mainPropery":{"diseaseId":10214,"diseaseName":"Neonatal intrahepatic cholestasis caused by citrin deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10214/neonatal-intrahepatic-cholestasis-caused-by-citrin-deficiency","synonyms":["NICCD","Neonatal-onset citrullinemia type II","Citrin deficiency","Neonatal-onset citrullinemia type 2"],"synonyms-with-source":[{"name":"NICCD"},{"name":"Neonatal-onset citrullinemia type II"},{"name":"Citrin deficiency"},{"name":"Neonatal-onset citrullinemia type 2"}],"identifiers":[{"identifierType":"OMIM","identifierId":"605814"},{"identifierType":"ORPHANET","identifierId":"247598"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":174,"resourceName":"Save Babies Through Screening Foundation, Inc","abbreviation":"","address1":"P.O. Box 2313","address2":"","address3":"","address4":"","address5":"","city":"Palm Harbor","state":"FL","zip":"34682-2313","country":"United States","phone":"","tty":"","tollFree":"888-454-3383","fax":"","email":"email@savebabies.org","url":"http://www.savebabies.org","freeText":""},{"resourceID":381,"resourceName":"National Urea Cycle Disorders Foundation","abbreviation":"","address1":"75 South Grand Avenue","address2":"","address3":"","address4":"","address5":"","city":"Pasadena","state":"CA","zip":"91105","country":"United States","phone":"+1-626-578-0833","tty":"","tollFree":"800-38-NUDCF (386-8233)","fax":"","email":"info@nucdf.org","url":"http://www.nucdf.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/605814' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=605814' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Neonatal intrahepatic cholestasis caused by citrin deficiency. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://www.ghr.nlm.nih.gov/condition=citrullinemia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Neonatal intrahepatic cholestasis caused by citrin deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":350,"resourceId":1167,"resourceName":"Baby's First Test","descriptionText":"<a href='https://www.babysfirsttest.org/newborn-screening/conditions/citrullinemia-type-ii' target='_blank'>Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":725,"resourceId":1420,"resourceName":"RDCRN - Urea Cycle Disorders Consortium Registry","descriptionText":"<p>The <a href='https://www.rarediseasesnetwork.org/cms/ucdc' target='_blank'>Urea Cycle Disorders Consortium</a> is a team of doctors, nurses, research coordinators, and research labs throughout the US, working together to improve the lives of people with Urea Cycle Disorders. The Urea Cycle Disorders Consortium maintains a registry for patients who wish toÂ be contacted about clinical research opportunities. </p><p style=\"LINE-HEIGHT: normal\">For more information on the registry see: <a href='http://rarediseasesnetwork.epi.usf.edu/ucdc/takeaction/index.htm ' target='_blank'>http://rarediseasesnetwork.epi.usf.edu/ucdc/takeaction/index.htm</a> </p>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":791,"resourceId":1472,"resourceName":"GeneReview - Urea cycle disorders","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK1217/' target='_blank'>GeneReviews</a> provides a current, expert-authored, peer-reviewed, full-text article urea cycle disorders in general that you may find helpful. GeneReview articles describe the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":792,"resourceId":1473,"resourceName":"MedlinePlus - Urea cycle disorders","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000372.htm ' target='_blank'>MedlinePlus.gov</a> provides more information on urea cycle disorders in general. MedlinePlus is a Web site designed by the National Library of Medicine to help you research your health questions.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":824,"resourceId":1519,"resourceName":"Citrullinemia 2","descriptionText":"The <a href='http://newbornscreeningcodes.nlm.nih.gov/nb/sc/condition/CIT-II ' target='_blank'>Newborn Screening Coding and Terminology Guide</a> has information on the standard codes used for  newborn screening tests. Using these standards helps compare data across different laboratories. This resource was created by the National Library of Medicine.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1321,"resourceId":1982,"resourceName":"National Newborn Screening and Global Resource Center","descriptionText":"<a href='https://www.newbornscreening.info/iva-isovaleric-acidemia/' target='_blank'>National Newborn Screening and Global Resource Center</a> (NNSGRC) provides information and resources in the area of newborn screening and genetics to benefit health professionals, the public health community, consumers and government officials.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/942435-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=247598' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1535,"resourceId":2166,"resourceName":"ACTion (ACT) sheet","descriptionText":"An  <a href='https://www.acmg.net/PDFLibrary/Citrullinemia.pdf' target='_blank'>ACTion (ACT) sheet </a> is available for this condition that describes the short-term actions a health professional should follow when an infant has a positive newborn screening result. ACT sheets were developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=citrin' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1546,"resourceId":2174,"resourceName":"Algorithm","descriptionText":"An <a href='https://www.acmg.net/PDFLibrary/Citrulline-Algorithm.pdf' target='_blank'>Algorithm</a> flowchart is available for this condition for determining the final diagnosis in an infant with a positive newborn screening result. Algorithms are developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:605814' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4856,"questionText":"What is neonatal intrahepatic cholestasis caused by citrin deficiency?","answerText":"<strong>Neonatal intrahepatic cholestasis caused by citrin deficiency </strong>(NICCD) is a&nbsp;liver condition is also known as&nbsp;neonatal-onset type II citrullinemia.&nbsp;NICCD blocks the flow of bile (a digestive fluid produced by the liver) and prevents the body from processing certain nutrients properly. This leads to transient <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000215.htm\" target=_blank>intrahepatic cholestasis</a> and variable liver&nbsp;dysfunction in children younger than one year of age.&nbsp;NICCD is generally not severe, and symptoms disappear by age one year with appropriate treatment.&nbsp;Years or even decades later, however, some of these&nbsp;individuals develop the characteristic features of <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10215/Citrullinemia_type_2.aspx\" target=_blank>adult-onset type II citrullinemia</a>. NICCD is caused by mutations in the&nbsp;<span class=geneSymbol><em><a href=\"http://ghr.nlm.nih.gov/gene/SLC25A13\" target=_blank>SLC25A13</a></em></span> gene. This condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> pattern.[1714] ","dateModified":"2011-07-11T15:17:00"},"basicQuestions":[{"questionId":4857,"questionText":"What are the signs and symptoms of&nbsp;neonatal intrahepatic cholestasis caused by citrin deficiency?","answerText":"Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD)&nbsp;is characterized by transient <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000215.htm\" target=_blank>intrahepatic cholestasis</a>, diffuse fatty liver, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000255.htm\" target=_blank>hepatic fibrosis</a>, low birth weight, growth retardation, hypoproteinemia, decreased <a href=\"http://labtestsonline.org/understanding/analytes/coagulation-factors/tab/test\" target=_blank>coagulation factors</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000571.htm\" target=_blank>hemolytic anemia</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003275.htm\" target=_blank>hepatomegaly</a>, variable liver dysfunction, and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000386.htm\" target=_blank>hypoglycemia</a> in children younger than one year of age. NICCD is generally not severe, and symptoms typically disappear by age one year with appropriate treatment. At around age two, children with NICCD begin to show a particular fondness for protein-rich and&nbsp;fatty foods and an aversion to sugary and carbohydrate-rich foods. One of more decades later, some&nbsp;of these individuals develop neuropsychiatric symptoms characteristic of <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10215/Citrullinemia_type_2.aspx\" target=_blank>adult-onset citrullinemia type II</a>.[3806]&nbsp;&nbsp;","dateModified":"2011-07-11T15:24:00","resourceClassificationName":"Symptoms","references":[{"referenceId":3806,"authors":"Kobayashi K, Saheki T","articleTitle":"Citrin Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"July 31, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1181/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":24842,"abbreviatedInquiry":"Why is adult onset citrullinemia type ll so common in Japan? What is the prognosis for this type of citrullinemia? Where can I find graphical data on the prevalence of citrullinemia worldwide?","caseQuestions":[{"questionId":2655,"questionText":"Why is adult-onset citrullinemia type ll so common in Japan?","answerText":"Some genetic disorders are more likely to occur among people who trace their ancestry to a particular geographic area. People in an ethnic group often share certain versions of their genes, which have been passed down from common ancestors. If one of these shared genes contains a disease-causing mutation, a particular genetic disorder may be more frequently seen in the group.\r\n<p><span style=\"font-size: 12pt;\"><br />\r\nThis is similar to what is seen in </span><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000527.htm\" target=\"_blank\" style=\"font-size: 12pt;\">sickle cell anemia</a><span style=\"font-size: 12pt;\">, which is more common in people of African, African-American, or Mediterranean heritage and </span><a href=\"http://ghr.nlm.nih.gov/condition=taysachsdisease\" target=\"_blank\" style=\"font-size: 12pt;\"><span style=\"color: #0000ee;\">Tay-Sachs disease</span></a><span style=\"font-size: 12pt;\">, which is more likely to occur among people of Ashkenazi (eastern and central European) Jewish or French Canadian ancestry.[1715]&nbsp;</span></p>\r\n<p>In addition,&nbsp;this condition has been most frequently reported in Japan and was initially described in that country, probably leading to a heightened clinical awareness not shared in the United States [and elsewhere]. Thus, the disorder could be significantly more common in other countries than originally believed.[1716]&nbsp;</p>","dateModified":"2016-12-28T00:00:00","references":[{"referenceId":1715,"authors":"","articleTitle":"Why are some genetics conditions more common in particular ethnic groups?","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2009","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/handbook/inheritance/ethnicgroup","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1716,"authors":"Roth KS","articleTitle":"Citrullinemia: Follow-up","bookWebsiteJournalTitle":"Medscape","date":"September 08, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/942435","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2656,"questionText":"What is the prognosis for individuals with adult-onset citrullinemia type ll?","answerText":"The prognosis for individuals with adult-onset citrullinemia type ll varies. In babies, the signs and symptoms usually resolve on their own. In adults, treatment may reduce the signs and symptoms of the condition. As adult-onset citrullinemia type ll can cause severe liver problems, untreated adults may need a liver transplant.[3806][12843]","dateModified":"2016-12-28T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3806,"authors":"Kobayashi K, Saheki T","articleTitle":"Citrin Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"July 31, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1181/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12843,"authors":"","articleTitle":"Citrullinemia, Type II","bookWebsiteJournalTitle":"baby's first test","date":"","volume":"","pages":"","url":"http://www.babysfirsttest.org/newborn-screening/conditions/citrullinemia-type-ii","dateAccessed":"2016-12-28T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2657,"questionText":"Where can I find graphical data on the worldwide prevalence of citrullinemia?","answerText":"We are not aware of any resources which graphically present the worldwide prevalence of citrullinemia. According to the <a href=\"http://www.ghr.nlm.nih.gov/condition=citrullinemia\" target=\"_blank\">Genetics Home Reference</a> page on this topic,&nbsp;classic citrullinemia is the most common form of the disorder, affecting about 1 in 57,000 people worldwide. Adult onset citrullinemia type ll is found primarily in the Japanese population, where it occurs in an estimated 1 in 100,000 to 230,000 individuals. Type ll also has been reported in other populations, including people from East Asia and the Middle East.[1714]<br />\r\n<br />","dateModified":"2016-12-28T00:00:00","references":[{"referenceId":1714,"authors":"","articleTitle":"Citrullinemia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2017","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/citrullinemia","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":3592,"phenoTypeName":"Decreased circulating antibody level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14468,"phenoTypeName":"Elevated alkaline phosphatase","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":2518,"phenoTypeName":"Elevated alpha-fetoprotein","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3758,"phenoTypeName":"Elevated gamma-glutamyltransferase level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13237,"phenoTypeName":"Elevated plasma citrulline","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4311,"phenoTypeName":"Hyperbilirubinemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1654,"phenoTypeName":"Hypergalactosemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13752,"phenoTypeName":"Hypertriglyceridemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14531,"phenoTypeName":"Hypoalbuminemia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":2176,"phenoTypeName":"Increased lactate dehydrogenase level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10276,"phenoTypeName":"Jaundice","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14576,"phenoTypeName":"Lactic acidosis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1361,"phenoTypeName":"Prolonged prothrombin time","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":7854,"phenoTypeName":"Abnormal circulating alanine concentration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7847,"phenoTypeName":"Abnormal circulating arginine concentration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7841,"phenoTypeName":"Abnormal circulating glutamine concentration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4090,"phenoTypeName":"Failure to thrive in infancy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5695,"phenoTypeName":"Hepatic steatosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8125,"phenoTypeName":"Hepatosplenomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13089,"phenoTypeName":"Hyperammonemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13837,"phenoTypeName":"Hyperlysinemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10923,"phenoTypeName":"Hypertyrosinemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":12939,"phenoTypeName":"Abnormal circulating serine concentration","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15539,"phenoTypeName":"Anemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10925,"phenoTypeName":"Decreased HDL cholesterol concentration","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8110,"phenoTypeName":"Gastrointestinal hemorrhage","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14568,"phenoTypeName":"Hypercholesterolemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10927,"phenoTypeName":"Hypermethioninemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4002,"phenoTypeName":"Hyperthreoninemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14582,"phenoTypeName":"Increased LDL cholesterol concentration","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6570,"phenoTypeName":"Increased urinary glycerol","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4083,"phenoTypeName":"Intrauterine growth retardation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4325,"phenoTypeName":"Ketonuria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10361,"phenoTypeName":"Poor appetite","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5624,"phenoTypeName":"Cataract","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":5689,"phenoTypeName":"Cirrhosis","percentRanges":"-"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","percentRanges":"-"},{"phenoTypeId":4082,"phenoTypeName":"Growth delay","percentRanges":"-"},{"phenoTypeId":5699,"phenoTypeName":"Intrahepatic cholestasis","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Neonatal_intrahepatic_cholestasis_caused_by_citrin_deficiency"}